Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07384702 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Adjuvant Clopidogrel in Staphylococcus Aureus Bacteremia

Name: Adjuvant Clopidogrel in Staphylococcus Aureus Bacteremia — clinical trial record (NCT07384702)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: CLOPI-SNAP

StatusNot Yet Recruiting

PhasePhase 2

SponsorFundación Pública Andaluza para la gestión de la Investigación en Sevilla

Started2026-06

View on ClinicalTrials.gov ↗

Amendment history

2026-02-03

Study Identification, Study Status, Study Design, Outcome Measures v1

Study title-60 characters

~~Phase 2 Multicenter Randomized Open-label Platform Trial of~~ Adjuvant Clopidogrel in Staphylococcus Aureus Bacteremia

2026-01-27

Original filing

Fundación Pública Andaluza para la gestión de la Investigación en Sevilla

27 trials monitored

See all monitored trials

The CLOPI-SNAP study is a randomized, multicenter, open-label clinical trial embedded within the SNAP (NCT 05137119) research platform. It constitutes a sub-study added to the core protocol for patients suffering Staphylococcus aureus bacteremia (SAB).

Trial Details

NCT Number	NCT07384702
Lead Sponsor	Fundación Pública Andaluza para la gestión de la Investigación en Sevilla Collaborators: University of Melbourne
Conditions	Bacteremia Due to Staphylococcus Aureus
Enrollment	230 participants
Start Date	2026-06
Primary Completion	2030-06 (estimated)
Study Completion	2030-06 (estimated)
Updated on ClinicalTrials.gov	2026-02-05